Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus

Zhu,Xiaohua; Li,Feng; Yang,Bo; Liang,Jun; Qin,Haihong; Xu,Jinhua

doi:10.3892/etm.2013.960

Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus

Authors:
- Xiaohua Zhu
- Feng Li
- Bo Yang
- Jun Liang
- Haihong Qin
- Jinhua Xu
View Affiliations

Affiliations: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
Published online on: February 18, 2013 https://doi.org/10.3892/etm.2013.960
Pages: 1219-1225

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of ultraviolet B (UVB) exposure on DNA methylation in patients with systemic lupus erythematosus (SLE) and its significance in the pathogenesis of SLE. T cells from 35 SLE patients and 21 healthy individuals were cultured and irradiated with UVB. The global DNA methylation profiles of the T cells obtained from the patients and controls following irradiation with UVB were assessed using specific monoclonal antibodies for 5‑methylcytosine and analyzed quantitatively through flow cytometry. Real‑time reverse transcription‑polymerase chain reaction (RT‑PCR) was used to analyze the levels of DNA methyltransferase 1 (DNMT1) and methyl CpG binding domain protein 2 (MBD2) in T cells from the patients and controls following UVB irradiation. Significant global DNA hypomethylation was observed in the SLE patients compared with the controls (P<0.01). The SLE patients also had significantly lower levels of DNMT1 mRNA expression (P<0.01) and significantly higher levels of MBD2 mRNA compared with the controls (P<0.01). DNA methylation was decreased following UVB irradiation at two different dosages and the DNA methylation levels of the patients with active SLE were more sensitive to UVB. The level of DNMT1 mRNA was decreased following UVB irradiation at the higher dosage in the patients with active SLE, but no significant difference was observed in MBD2 mRNA expression. UVB exposure is able to inhibit DNA methylation and DNMT1 mRNA expression, which is subsequently involved in the epigenetic mechanism of SLE. The process by which DNA hypomethylation occurs in patients with SLE is complicated and the multiple factors that are involved in DNA methylation and demethylation events require further study.

View Figures

View References

1	Sestak AL, Nath SK, Sawalha AH and Harley JB: Current status of lupus genetics. Arthritis Res Ther. 9:2102007. View Article : Google Scholar
2	Jönsen A, Bengtsson AA, Nived O, Truedsson L and Sturfelt G: Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity. 40:613–617. 2007.PubMed/NCBI
3	Attwood JT, Yung RL and Richardson BC: DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 59:241–257. 2002. View Article : Google Scholar : PubMed/NCBI
4	Richardson BC: Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr. 132(8 Suppl): 2401S–2405S. 2002.PubMed/NCBI
5	Richardson BC, Strahler JR, Pivirotto TS, et al: Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35:647–662. 1992. View Article : Google Scholar : PubMed/NCBI
6	Yung R, Powers D, Johnson K, et al: Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest. 97:2866–2871. 1996. View Article : Google Scholar
7	Quddus J, Johnson KJ, Gavalchin J, et al: Treating activated CD4⁺ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest. 92:38–53. 1993.
8	Kaplan MJ, Lu Q, Wu A, Attwood J and Richardson B: Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4⁺ lupus T cells. J Immunol. 172:3652–3661. 2004. View Article : Google Scholar : PubMed/NCBI
9	Lu Q, Ray D, Gutsch D and Richardson B: Effect of DNA methylation and chromatin structure on ITGAL expression. Blood. 99:4503–4508. 2002. View Article : Google Scholar : PubMed/NCBI
10	Nakao M: Epigenetics: interaction of DNA methylation and chromatin. Gene. 278:25–31. 2001. View Article : Google Scholar : PubMed/NCBI
11	Richardson B and Yung R: Role of DNA methylation in the regulation of cell function. J Lab Clin Med. 134:333–340. 1999. View Article : Google Scholar : PubMed/NCBI
12	Detich N, Theberge J and Szyf M: Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem. 277:35791–35794. 2002. View Article : Google Scholar : PubMed/NCBI
13	Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271–1277. 1982. View Article : Google Scholar : PubMed/NCBI
14	Wysenbeek AJ, Block DA and Fries JF: Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis. 48:461–463. 1989. View Article : Google Scholar : PubMed/NCBI
15	Lehmann P, Hölzle E, Kind P, Goerz G and Plewig G: Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol. 22:181–187. 1990. View Article : Google Scholar : PubMed/NCBI
16	Bombardier C, Gladman DD, Urowitz MB, Caron D and Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
17	WHO: Global Solar UV Index: A Practical Guide. World Health Organization; Geneva, Switzerland: 2002
18	Gies P: Australia has more than enough solar UV radiation. Clin Exp Optom. 86:71–73. 2003. View Article : Google Scholar : PubMed/NCBI
19	Habib M, Fares F, Bourgeois CA, et al: DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res. 249:46–53. 1999. View Article : Google Scholar : PubMed/NCBI
20	Milutinovic S, Zhuang Q, Niveleau A and Szyf M: Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem. 278:14985–14995. 2003. View Article : Google Scholar : PubMed/NCBI
21	Wang X and Seed B: A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 31:e1542003. View Article : Google Scholar : PubMed/NCBI
22	Fuke C, Shimabukuro M, Petronis A, et al: Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 68:196–204. 2004. View Article : Google Scholar : PubMed/NCBI
23	Klinman DM, Mushinski JF, Honda M, et al: Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med. 163:1292–1307. 1986. View Article : Google Scholar : PubMed/NCBI
24	Tsokos GC and Kammer GM: Molecular aberrations in human systemic lupus erythematosus. Mol Med Today. 6:418–424. 2000. View Article : Google Scholar : PubMed/NCBI
25	Surani MA: Imprinting and the initiation of gene silencing in the germ line. Cell. 93:309–312. 1998. View Article : Google Scholar : PubMed/NCBI
26	Ng HH and Bird A: DNA methylation and chromatin modification. Curr Opin Genet Dev. 9:158–163. 1999. View Article : Google Scholar
27	Knight SJ, Flannery AV, Hirst MC, et al: Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 74:127–134. 1993. View Article : Google Scholar : PubMed/NCBI
28	Xu GL, Bestor TH, Bourc’his D, et al: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 402:187–191. 1999. View Article : Google Scholar : PubMed/NCBI
29	Yung R, Chang S, Hemati N, Johnson K and Richardson B: Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. Arthritis Rheum. 40:1436–1443. 1997. View Article : Google Scholar : PubMed/NCBI
30	Yung RL, Quddus J, Chrisp CE, Johnson KJ and Richardson BC: Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol. 154:3025–3035. 1995.PubMed/NCBI
31	Sawalha AH and Richardson B: DNA methylation in the pathogenesis of systemic lupus erythematosus. Curr Pharmacogenomics. 3:73–78. 2005. View Article : Google Scholar
32	Deng C, Yang J, Scott J, Hanash S and Richardson BC: Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem. 379:1113–1120. 1998. View Article : Google Scholar : PubMed/NCBI
33	Okano M, Xie S and Li E: Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 19:219–220. 1998. View Article : Google Scholar : PubMed/NCBI
34	Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I and Hashimoto H: Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin Exp Rheumatol. 21:733–738. 2003.PubMed/NCBI
35	Vertino PM, Yen RW, Gao J and Baylin SB: De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol. 16:4555–4565. 1996.PubMed/NCBI
36	Fan G and Hutnick L: Methyl-CpG binding proteins in the nervous system. Cell Res. 15:255–261. 2005. View Article : Google Scholar : PubMed/NCBI
37	Klose RJ and Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 31:89–97. 2006. View Article : Google Scholar : PubMed/NCBI
38	Bhattacharya SK, Ramchandani S, Cervoni N and Szyf M: A mammalian protein with specific demethylase activity for mCpG DNA. Nature. 397:579–583. 1999. View Article : Google Scholar : PubMed/NCBI
39	Ng HH, Zhang Y, Hendrich B, et al: MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet. 23:58–61. 1999. View Article : Google Scholar : PubMed/NCBI
40	Kastan MB, Gowans BJ and Lieberman MW: Methylation of deoxycytidine incorporated by excision-repair synthesis of DNA. Cell. 30:509–516. 1982. View Article : Google Scholar : PubMed/NCBI
41	Lieberman MW, Beach LR and Palmiter RD: Ultraviolet radiation-induced metallothionein-I gene activation is associated with extensive DNA demethylation. Cell. 35:207–214. 1983. View Article : Google Scholar : PubMed/NCBI
42	Zhang Z, Deng C, Lu Q and Richardson B: Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter. Mech Ageing Dev. 123:1257–1268. 2002. View Article : Google Scholar : PubMed/NCBI
43	Balada E, Ordi-Ros J and Vilardell-Tarrés M: DNA methylation and systemic lupus erythematosus. Ann NY Acad Sci. 1108:127–136. 2007. View Article : Google Scholar : PubMed/NCBI
44	Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S and Johnson M: Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33:1665–1673. 1990. View Article : Google Scholar : PubMed/NCBI
45	Nyce J, Liu L and Jones PA: Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nucleic Acids Res. 14:4353–4367. 1986. View Article : Google Scholar : PubMed/NCBI
46	Deng C, Kaplan MJ, Yang J, et al: Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44:397–407. 2001. View Article : Google Scholar : PubMed/NCBI
47	Yoder JA, Soman NS, Verdine GL and Bestor TH: DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J Mol Biol. 270:385–395. 1997. View Article : Google Scholar : PubMed/NCBI
48	Lei W, Luo Y, Lei W, et al: Abnormal DNA methylation in CD4⁺ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol. 38:369–374. 2009.PubMed/NCBI